Skip to main content
PMC home page
Gut logoLink to Gut
. 2001 Apr;48(4):522–525. doi: 10.1136/gut.48.4.522

Flexible sigmoidoscopy and the changing distribution of colorectal cancer: implications for screening

K McCallion 1, R Mitchell 1, R Wilson 1, F Kee 1, R Watson 1, J Collins 1, K Gardiner 1
PMCID: PMC1728246  PMID: 11247897

Abstract

BACKGROUND AND AIMS—There has been a significant proximal shift in the distribution of colorectal cancer (CRC) in Northern Ireland over recent decades. The aim of this study was to investigate the potential implications of this proximal shift in CRC distribution on the efficacy of flexible sigmoidoscopy (FS) as a screening tool.
PATIENTS AND METHODS—The site distribution of 5153 CRCs was available from the Northern Ireland Colorectal Cancer Register for the period 1990-1997. Similar data on 1241 CRCs between 1976 and 1978 were available from a previous study. Data on the site reached by FS were obtained from a prospectively collected endoscopy database at one of Northern Ireland's main teaching hospitals for the period 1993-1998.
RESULTS—There was a significant proximal shift in CRC distribution between the two periods (23.5% proximal to the splenic flexure between 1976 and 1978 v 36.7% between 1990 and 1997; p<0.001). The descending colon was visualised during 74.4% of FS examinations. By combining the observed extent of FS examination with CRC site distribution, it was calculated that FS could have visualised 68.8% of CRCs between 1976 and 1978 but only 56.0% between 1990 and 1997. Extrapolating these data to a Northern Ireland screening programme involving FS and faecal occult blood testing suggests that significantly more CRCs could have been detected between 1976 and 1978 than between 1990 and 1997 (51.7% v 48.2%, respectively; p=0.03).
CONCLUSIONS—This study confirms the previously documented left to right shift in CRC distribution in Northern Ireland and demonstrates that if this shift continues, FS will become less successful as a screening tool than is currently predicted.


Keywords: colorectal cancer; screening; flexible sigmoidoscopy; endoscopy

Full Text

The Full Text of this article is available as a PDF (118.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkin W. S. Flexible sigmoidoscopy as a mass screening tool. Eur J Gastroenterol Hepatol. 1998 Mar;10(3):219–223. doi: 10.1097/00042737-199803000-00005. [DOI] [PubMed] [Google Scholar]
  2. Beart R. W., Melton L. J., 3rd, Maruta M., Dockerty M. B., Frydenberg H. B., O'Fallon W. M. Trends in right and left-sided colon cancer. Dis Colon Rectum. 1983 Jun;26(6):393–398. doi: 10.1007/BF02553382. [DOI] [PubMed] [Google Scholar]
  3. Dunlop M. G. The case for surveillance of high-risk' families. Eur J Gastroenterol Hepatol. 1998 Mar;10(3):229–233. doi: 10.1097/00042737-199803000-00007. [DOI] [PubMed] [Google Scholar]
  4. Fletcher R. H., Farraye F. A. Screening flexible sigmoidoscopy: effectiveness is not enough. Gastroenterology. 1999 Aug;117(2):486–488. doi: 10.1053/gast.1999.0029900486. [DOI] [PubMed] [Google Scholar]
  5. Hardcastle J. D., Chamberlain J. O., Robinson M. H., Moss S. M., Amar S. S., Balfour T. W., James P. D., Mangham C. M. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996 Nov 30;348(9040):1472–1477. doi: 10.1016/S0140-6736(96)03386-7. [DOI] [PubMed] [Google Scholar]
  6. Jen J., Johnson C., Levin B. Molecular approaches for colorectal cancer screening. Eur J Gastroenterol Hepatol. 1998 Mar;10(3):213–217. doi: 10.1097/00042737-199803000-00004. [DOI] [PubMed] [Google Scholar]
  7. Kadish S. L., Faigel D. O., Long W. B. Safe duodenoscopic intubation in a patient with a large Zenker's diverticulum. Gastrointest Endosc. 1996 Jul;44(1):101–102. doi: 10.1016/s0016-5107(96)70246-8. [DOI] [PubMed] [Google Scholar]
  8. Kee F., Collins B. J., Patterson C. C. Incidence and site distribution of colorectal cancer in Northern Ireland. Ulster Med J. 1990 Oct;59(2):155–160. [PMC free article] [PubMed] [Google Scholar]
  9. Kee F., Wilson R. H., Gilliland R., Sloan J. M., Rowlands B. J., Moorehead R. J. Changing site distribution of colorectal cancer. BMJ. 1992 Jul 18;305(6846):158–158. doi: 10.1136/bmj.305.6846.158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kewenter J., Brevinge H., Engarås B., Haglind E. The yield of flexible sigmoidoscopy and double-contrast barium enema in the diagnosis of neoplasms in the large bowel in patients with a positive Hemoccult test. Endoscopy. 1995 Feb;27(2):159–163. doi: 10.1055/s-2007-1005655. [DOI] [PubMed] [Google Scholar]
  11. Kronborg O., Fenger C., Olsen J., Jørgensen O. D., Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996 Nov 30;348(9040):1467–1471. doi: 10.1016/S0140-6736(96)03430-7. [DOI] [PubMed] [Google Scholar]
  12. Landis S. H., Murray T., Bolden S., Wingo P. A. Cancer statistics, 1998. CA Cancer J Clin. 1998 Jan-Feb;48(1):6–29. doi: 10.3322/canjclin.48.1.6. [DOI] [PubMed] [Google Scholar]
  13. Lang C. A., Ransohoff D. F. What can we conclude from the randomized controlled trials of fecal occult blood test screening? Eur J Gastroenterol Hepatol. 1998 Mar;10(3):199–204. doi: 10.1097/00042737-199803000-00002. [DOI] [PubMed] [Google Scholar]
  14. Lieberman D. Colonoscopy as a mass screening tool. Eur J Gastroenterol Hepatol. 1998 Mar;10(3):225–228. doi: 10.1097/00042737-199803000-00006. [DOI] [PubMed] [Google Scholar]
  15. Macrae F. A., St John D. J. Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology. 1982 May;82(5 Pt 1):891–898. [PubMed] [Google Scholar]
  16. Mandel J. S., Bond J. H., Church T. R., Snover D. C., Bradley G. M., Schuman L. M., Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993 May 13;328(19):1365–1371. doi: 10.1056/NEJM199305133281901. [DOI] [PubMed] [Google Scholar]
  17. Muto T., Bussey H. J., Morson B. C. The evolution of cancer of the colon and rectum. Cancer. 1975 Dec;36(6):2251–2270. doi: 10.1002/cncr.2820360944. [DOI] [PubMed] [Google Scholar]
  18. Northover J. Screening for bowel cancer. Overview. Eur J Gastroenterol Hepatol. 1998 Mar;10(3):195–197. [PubMed] [Google Scholar]
  19. Rex D. K., Chak A., Vasudeva R., Gross T., Lieberman D., Bhattacharya I., Sack E., Wiersema M., Farraye F., Wallace M. Prospective determination of distal colon findings in average-risk patients with proximal colon cancer. Gastrointest Endosc. 1999 Jun;49(6):727–730. doi: 10.1016/s0016-5107(99)70290-7. [DOI] [PubMed] [Google Scholar]
  20. Rozen P., Ron E., Fireman Z., Hallak A., Grossman A., Baratz M., Rattan J., Gilat T. The relative value of fecal occult blood tests and flexible sigmoidoscopy in screening for large bowel neoplasia. Cancer. 1987 Nov 15;60(10):2553–2558. doi: 10.1002/1097-0142(19871115)60:10<2553::aid-cncr2820601034>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  21. Schroy P. C., Heeren T., Bliss C. M., Pincus J., Wilson S., Prout M. Implementation of on-site screening sigmoidoscopy positively influences utilization by primary care providers. Gastroenterology. 1999 Aug;117(2):304–311. doi: 10.1053/gast.1999.0029900304. [DOI] [PubMed] [Google Scholar]
  22. Winawer S. J., Zauber A. G., Ho M. N., O'Brien M. J., Gottlieb L. S., Sternberg S. S., Waye J. D., Schapiro M., Bond J. H., Panish J. F. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993 Dec 30;329(27):1977–1981. doi: 10.1056/NEJM199312303292701. [DOI] [PubMed] [Google Scholar]
  23. Young G. P. Screening for colorectal cancer: alternative faecal occult blood tests. Eur J Gastroenterol Hepatol. 1998 Mar;10(3):205–212. doi: 10.1097/00042737-199803000-00003. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES